Premarket Mover: aTyr Pharma Inc (LIFE) Down 2.25%

aTyr Pharma Inc (LIFE) is lower by Wednesday morning, with the stock decreasing -2.25% in pre-market trading to 11.74. LIFE's short-term technical score of 64 indicates that the stock has traded more bullishly over the last month than 64% of stocks on the market. In the Biotechnology industry, which ranks 140 out of 146 industries, aTyr Pharma Inc ranks higher than 91% of stocks. aTyr Pharma Inc has risen 161.66% over the past month, closing at $5.25 on August 25. During this period of time, the stock fell as low as $5.19 and as high as $12.97. LIFE has an average analyst recommendation of Strong Buy. The company has an average price target of $19.25.

LIFE has an Overall Score of 76. Find out what this means to you and get the rest of the rankings on LIFE!

See Full LIFE Report

aTyr Pharma Inc has a Long-Term Technical rank of 100. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 0% of the market scoring higher. In the Biotechnology industry which is number 126 by this metric, LIFE ranks better than 100% of stocks.

Important Dates for Investors in LIFE:

-aTyr Pharma Inc is set to release earnings on 11/8/2021. During their last earnings release the company posted EPS of $-2.29. -We do not have a set dividend date for aTyr Pharma Inc at this time. Click Here To Get The Full Report on aTyr Pharma Inc (LIFE)